Click for best price
PEGylated Drugs Market Size, Share 2022
This report contains market size and forecasts of PEGylated Drugs in Global, including the following market information:
Global PEGylated Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global PEGylated Drugs market was valued at 7206.3 million in 2021 and is projected to reach US$ 8691.5 million by 2028, at a CAGR of 2.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Macromolecular Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of PEGylated Drugs include AstraZeneca, Bayer Healthcare, Biogen, BioMarin Pharmaceutical Inc, Coherus BioSciences, Enzon, Horizon Therapeutics, Leadiant Biosciences, Inc. and Merck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We has surveyed the PEGylated Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global PEGylated Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global PEGylated Drugs Market Segment Percentages, by Type, 2021 (%)
Macromolecular Drugs
Small Molecular Drugs
Nanoparticles
Global PEGylated Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global PEGylated Drugs Market Segment Percentages, by Application, 2021 (%)
Cancer
Hepatitis C
Leukemia
Severe Combined Immunodeficiency Disease
Rheumatoid Arthritis
Crohn Disease
Others
Global PEGylated Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global PEGylated Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies PEGylated Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies PEGylated Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Bayer Healthcare
Biogen
BioMarin Pharmaceutical Inc
Coherus BioSciences
Enzon
Horizon Therapeutics
Leadiant Biosciences, Inc.
Merck
Mylan
Novo Nordisk
Pfizer
Roche
Sandoz
Servier Pharmaceuticals LLC
Takeda Pharmaceutical Company Limited
| Report Attributes |
Report Details |
| Report Title |
PEGylated Drugs Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
100 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 PEGylated Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global PEGylated Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global PEGylated Drugs Overall Market Size
2.1 Global PEGylated Drugs Market Size: 2021 VS 2028
2.2 Global PEGylated Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top PEGylated Drugs Players in Global Market
3.2 Top Global PEGylated Drugs Companies Ranked by Revenue
3.3 Global PEGylated Drugs Revenue by Companies
3.4 Top 3 and Top 5 PEGylated Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies PEGylated Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 PEGylated Drugs Players in Global Market
3.6.1 List of Global Tier 1 PEGylated Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 PEGylated Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global PEGylated Drugs Market Size Markets, 2021 & 2028
4.1.2 Macromolecular Drugs
4.1.3 Small Molecular Drugs
4.1.4 Nanoparticles
4.2 By Type - Global PEGylated Drugs Revenue & Forecasts
4.2.1 By Type - Global PEGylated Drugs Revenue, 2017-2022
4.2.2 By Type - Global PEGylated Drugs Revenue, 2023-2028
4.2.3 By Type - Global PEGylated Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global PEGylated Drugs Market Size, 2021 & 2028
5.1.2 Cancer
5.1.3 Hepatitis C
5.1.4 Leukemia
5.1.5 Severe Combined Immunodeficiency Disease
5.1.6 Rheumatoid Arthritis
5.1.7 Crohn Disease
5.1.8 Others
5.2 By Application - Global PEGylated Drugs Revenue & Forecasts
5.2.1 By Application - Global PEGylated Drugs Revenue, 2017-2022
5.2.2 By Application - Global PEGylated Drugs Revenue, 2023-2028
5.2.3 By Application - Global PEGylated Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global PEGylated Drugs Market Size, 2021 & 2028
6.2 By Region - Global PEGylated Drugs Revenue & Forecasts
6.2.1 By Region - Global PEGylated Drugs Revenue, 2017-2022
6.2.2 By Region - Global PEGylated Drugs Revenue, 2023-2028
6.2.3 By Region - Global PEGylated Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America PEGylated Drugs Revenue, 2017-2028
6.3.2 US PEGylated Drugs Market Size, 2017-2028
6.3.3 Canada PEGylated Drugs Market Size, 2017-2028
6.3.4 Mexico PEGylated Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe PEGylated Drugs Revenue, 2017-2028
6.4.2 Germany PEGylated Drugs Market Size, 2017-2028
6.4.3 France PEGylated Drugs Market Size, 2017-2028
6.4.4 U.K. PEGylated Drugs Market Size, 2017-2028
6.4.5 Italy PEGylated Drugs Market Size, 2017-2028
6.4.6 Russia PEGylated Drugs Market Size, 2017-2028
6.4.7 Nordic Countries PEGylated Drugs Market Size, 2017-2028
6.4.8 Benelux PEGylated Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia PEGylated Drugs Revenue, 2017-2028
6.5.2 China PEGylated Drugs Market Size, 2017-2028
6.5.3 Japan PEGylated Drugs Market Size, 2017-2028
6.5.4 South Korea PEGylated Drugs Market Size, 2017-2028
6.5.5 Southeast Asia PEGylated Drugs Market Size, 2017-2028
6.5.6 India PEGylated Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America PEGylated Drugs Revenue, 2017-2028
6.6.2 Brazil PEGylated Drugs Market Size, 2017-2028
6.6.3 Argentina PEGylated Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa PEGylated Drugs Revenue, 2017-2028
6.7.2 Turkey PEGylated Drugs Market Size, 2017-2028
6.7.3 Israel PEGylated Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia PEGylated Drugs Market Size, 2017-2028
6.7.5 UAE PEGylated Drugs Market Size, 2017-2028
7 Players Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Corporate Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca PEGylated Drugs Major Product Offerings
7.1.4 AstraZeneca PEGylated Drugs Revenue in Global Market (2017-2022)
7.1.5 AstraZeneca Key News
7.2 Bayer Healthcare
7.2.1 Bayer Healthcare Corporate Summary
7.2.2 Bayer Healthcare Business Overview
7.2.3 Bayer Healthcare PEGylated Drugs Major Product Offerings
7.2.4 Bayer Healthcare PEGylated Drugs Revenue in Global Market (2017-2022)
7.2.5 Bayer Healthcare Key News
7.3 Biogen
7.3.1 Biogen Corporate Summary
7.3.2 Biogen Business Overview
7.3.3 Biogen PEGylated Drugs Major Product Offerings
7.3.4 Biogen PEGylated Drugs Revenue in Global Market (2017-2022)
7.3.5 Biogen Key News
7.4 BioMarin Pharmaceutical Inc
7.4.1 BioMarin Pharmaceutical Inc Corporate Summary
7.4.2 BioMarin Pharmaceutical Inc Business Overview
7.4.3 BioMarin Pharmaceutical Inc PEGylated Drugs Major Product Offerings
7.4.4 BioMarin Pharmaceutical Inc PEGylated Drugs Revenue in Global Market (2017-2022)
7.4.5 BioMarin Pharmaceutical Inc Key News
7.5 Coherus BioSciences
7.5.1 Coherus BioSciences Corporate Summary
7.5.2 Coherus BioSciences Business Overview
7.5.3 Coherus BioSciences PEGylated Drugs Major Product Offerings
7.5.4 Coherus BioSciences PEGylated Drugs Revenue in Global Market (2017-2022)
7.5.5 Coherus BioSciences Key News
7.6 Enzon
7.6.1 Enzon Corporate Summary
7.6.2 Enzon Business Overview
7.6.3 Enzon PEGylated Drugs Major Product Offerings
7.6.4 Enzon PEGylated Drugs Revenue in Global Market (2017-2022)
7.6.5 Enzon Key News
7.7 Horizon Therapeutics
7.7.1 Horizon Therapeutics Corporate Summary
7.7.2 Horizon Therapeutics Business Overview
7.7.3 Horizon Therapeutics PEGylated Drugs Major Product Offerings
7.7.4 Horizon Therapeutics PEGylated Drugs Revenue in Global Market (2017-2022)
7.7.5 Horizon Therapeutics Key News
7.8 Leadiant Biosciences, Inc.
7.8.1 Leadiant Biosciences, Inc. Corporate Summary
7.8.2 Leadiant Biosciences, Inc. Business Overview
7.8.3 Leadiant Biosciences, Inc. PEGylated Drugs Major Product Offerings
7.8.4 Leadiant Biosciences, Inc. PEGylated Drugs Revenue in Global Market (2017-2022)
7.8.5 Leadiant Biosciences, Inc. Key News
7.9 Merck
7.9.1 Merck Corporate Summary
7.9.2 Merck Business Overview
7.9.3 Merck PEGylated Drugs Major Product Offerings
7.9.4 Merck PEGylated Drugs Revenue in Global Market (2017-2022)
7.9.5 Merck Key News
7.10 Mylan
7.10.1 Mylan Corporate Summary
7.10.2 Mylan Business Overview
7.10.3 Mylan PEGylated Drugs Major Product Offerings
7.10.4 Mylan PEGylated Drugs Revenue in Global Market (2017-2022)
7.10.5 Mylan Key News
7.11 Novo Nordisk
7.11.1 Novo Nordisk Corporate Summary
7.11.2 Novo Nordisk Business Overview
7.11.3 Novo Nordisk PEGylated Drugs Major Product Offerings
7.11.4 Novo Nordisk PEGylated Drugs Revenue in Global Market (2017-2022)
7.11.5 Novo Nordisk Key News
7.12 Pfizer
7.12.1 Pfizer Corporate Summary
7.12.2 Pfizer Business Overview
7.12.3 Pfizer PEGylated Drugs Major Product Offerings
7.12.4 Pfizer PEGylated Drugs Revenue in Global Market (2017-2022)
7.12.5 Pfizer Key News
7.13 Roche
7.13.1 Roche Corporate Summary
7.13.2 Roche Business Overview
7.13.3 Roche PEGylated Drugs Major Product Offerings
7.13.4 Roche PEGylated Drugs Revenue in Global Market (2017-2022)
7.13.5 Roche Key News
7.14 Sandoz
7.14.1 Sandoz Corporate Summary
7.14.2 Sandoz Business Overview
7.14.3 Sandoz PEGylated Drugs Major Product Offerings
7.14.4 Sandoz PEGylated Drugs Revenue in Global Market (2017-2022)
7.14.5 Sandoz Key News
7.15 Servier Pharmaceuticals LLC
7.15.1 Servier Pharmaceuticals LLC Corporate Summary
7.15.2 Servier Pharmaceuticals LLC Business Overview
7.15.3 Servier Pharmaceuticals LLC PEGylated Drugs Major Product Offerings
7.15.4 Servier Pharmaceuticals LLC PEGylated Drugs Revenue in Global Market (2017-2022)
7.15.5 Servier Pharmaceuticals LLC Key News
7.16 Takeda Pharmaceutical Company Limited
7.16.1 Takeda Pharmaceutical Company Limited Corporate Summary
7.16.2 Takeda Pharmaceutical Company Limited Business Overview
7.16.3 Takeda Pharmaceutical Company Limited PEGylated Drugs Major Product Offerings
7.16.4 Takeda Pharmaceutical Company Limited PEGylated Drugs Revenue in Global Market (2017-2022)
7.16.5 Takeda Pharmaceutical Company Limited Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. PEGylated Drugs Market Opportunities & Trends in Global Market
Table 2. PEGylated Drugs Market Drivers in Global Market
Table 3. PEGylated Drugs Market Restraints in Global Market
Table 4. Key Players of PEGylated Drugs in Global Market
Table 5. Top PEGylated Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global PEGylated Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global PEGylated Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies PEGylated Drugs Product Type
Table 9. List of Global Tier 1 PEGylated Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 PEGylated Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global PEGylated Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - PEGylated Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - PEGylated Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global PEGylated Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - PEGylated Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - PEGylated Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global PEGylated Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global PEGylated Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global PEGylated Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America PEGylated Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America PEGylated Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe PEGylated Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe PEGylated Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia PEGylated Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia PEGylated Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America PEGylated Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America PEGylated Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa PEGylated Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa PEGylated Drugs Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca Corporate Summary
Table 31. AstraZeneca PEGylated Drugs Product Offerings
Table 32. AstraZeneca PEGylated Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Bayer Healthcare Corporate Summary
Table 34. Bayer Healthcare PEGylated Drugs Product Offerings
Table 35. Bayer Healthcare PEGylated Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Biogen Corporate Summary
Table 37. Biogen PEGylated Drugs Product Offerings
Table 38. Biogen PEGylated Drugs Revenue (US$, Mn), (2017-2022)
Table 39. BioMarin Pharmaceutical Inc Corporate Summary
Table 40. BioMarin Pharmaceutical Inc PEGylated Drugs Product Offerings
Table 41. BioMarin Pharmaceutical Inc PEGylated Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Coherus BioSciences Corporate Summary
Table 43. Coherus BioSciences PEGylated Drugs Product Offerings
Table 44. Coherus BioSciences PEGylated Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Enzon Corporate Summary
Table 46. Enzon PEGylated Drugs Product Offerings
Table 47. Enzon PEGylated Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Horizon Therapeutics Corporate Summary
Table 49. Horizon Therapeutics PEGylated Drugs Product Offerings
Table 50. Horizon Therapeutics PEGylated Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Leadiant Biosciences, Inc. Corporate Summary
Table 52. Leadiant Biosciences, Inc. PEGylated Drugs Product Offerings
Table 53. Leadiant Biosciences, Inc. PEGylated Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Merck Corporate Summary
Table 55. Merck PEGylated Drugs Product Offerings
Table 56. Merck PEGylated Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Mylan Corporate Summary
Table 58. Mylan PEGylated Drugs Product Offerings
Table 59. Mylan PEGylated Drugs Revenue (US$, Mn), (2017-2022)
Table 60. Novo Nordisk Corporate Summary
Table 61. Novo Nordisk PEGylated Drugs Product Offerings
Table 62. Novo Nordisk PEGylated Drugs Revenue (US$, Mn), (2017-2022)
Table 63. Pfizer Corporate Summary
Table 64. Pfizer PEGylated Drugs Product Offerings
Table 65. Pfizer PEGylated Drugs Revenue (US$, Mn), (2017-2022)
Table 66. Roche Corporate Summary
Table 67. Roche PEGylated Drugs Product Offerings
Table 68. Roche PEGylated Drugs Revenue (US$, Mn), (2017-2022)
Table 69. Sandoz Corporate Summary
Table 70. Sandoz PEGylated Drugs Product Offerings
Table 71. Sandoz PEGylated Drugs Revenue (US$, Mn), (2017-2022)
Table 72. Servier Pharmaceuticals LLC Corporate Summary
Table 73. Servier Pharmaceuticals LLC PEGylated Drugs Product Offerings
Table 74. Servier Pharmaceuticals LLC PEGylated Drugs Revenue (US$, Mn), (2017-2022)
Table 75. Takeda Pharmaceutical Company Limited Corporate Summary
Table 76. Takeda Pharmaceutical Company Limited PEGylated Drugs Product Offerings
Table 77. Takeda Pharmaceutical Company Limited PEGylated Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. PEGylated Drugs Segment by Type in 2021
Figure 2. PEGylated Drugs Segment by Application in 2021
Figure 3. Global PEGylated Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global PEGylated Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global PEGylated Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by PEGylated Drugs Revenue in 2021
Figure 8. By Type - Global PEGylated Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global PEGylated Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global PEGylated Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America PEGylated Drugs Revenue Market Share, 2017-2028
Figure 12. US PEGylated Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada PEGylated Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico PEGylated Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe PEGylated Drugs Revenue Market Share, 2017-2028
Figure 16. Germany PEGylated Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France PEGylated Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. PEGylated Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy PEGylated Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia PEGylated Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries PEGylated Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux PEGylated Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia PEGylated Drugs Revenue Market Share, 2017-2028
Figure 24. China PEGylated Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan PEGylated Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea PEGylated Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia PEGylated Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India PEGylated Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America PEGylated Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil PEGylated Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina PEGylated Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa PEGylated Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey PEGylated Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel PEGylated Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia PEGylated Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE PEGylated Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca PEGylated Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bayer Healthcare PEGylated Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Biogen PEGylated Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. BioMarin Pharmaceutical Inc PEGylated Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Coherus BioSciences PEGylated Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Enzon PEGylated Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Horizon Therapeutics PEGylated Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Leadiant Biosciences, Inc. PEGylated Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Merck PEGylated Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Mylan PEGylated Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Novo Nordisk PEGylated Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Pfizer PEGylated Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Roche PEGylated Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Sandoz PEGylated Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Servier Pharmaceuticals LLC PEGylated Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Takeda Pharmaceutical Company Limited PEGylated Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
